News | 01 December 2025
SciSparc acquires Xylo Technologies' innovative endoscopic portfolio
The MUSE system offers a minimally invasive solution for treating gastroesophageal reflux disease
The MUSE system offers a minimally invasive solution for treating gastroesophageal reflux disease
The oral, film-coated tablet is licensed for patients whose cancer has returned during or shortly after hormone therapy
Abdomen-pelvis CT is the nation’s highest-volume CT category
The receipt of this order further strengthens the company's position in the global pharmaceutical market
Amrutanjan is also rolling out its new campaign, 'Har Dard Mitaye'
This distinction is testament to LHWRF's dedication to excellence, transparency, and impact in the realm of social responsibility
Nitrosamines have prompted evolving global guidelines that demand rigorous industry oversight
GV20 received an upfront payment and is eligible for additional milestone payments
The fresh capital will propel Cordance into its first-in-human clinical trial
Clinical studies conducted in India demonstrated that this nebulized triple therapy rapidly improves lung function and offers better control of breathlessness
India's pharmaceutical sector is rapidly shifting from a generics-led foundation to an innovation-driven ecosystem
Renalyx will continue operating as an independent unit within the group
The Complement Laboratory is equipped with state-of-the-art immunoturbidimetric and ELISA platforms and adheres to CAP and NABL accreditation standards
RK Pharma will manufacture and supply the finished product, while Zydus will be responsible for the NDA submission and commercialization of the product in the US
Valneva will consolidate its French operations at its Lyon site and close its Nantes location
The Signia Circular Stapler is the only circular stapler on the market with integrated leak testing and features designed to minimize risk
A key highlight will be Brenntag’s qualified amino acids portfolio
Globally, Abbott has received reports of 736 severe adverse events linked to the issue, including seven deaths (none in the US)
Suven Life Sciences achieved 100% patient enrolment in Phase-2b clinical trial of Ropanicant for MDO
Subscribe To Our Newsletter & Stay Updated
